bf/NASDAQ:RIGL_icon.jpeg

NASDAQ:RIGL

Rigel Pharmaceuticals, Inc.

  • Stock

USD

Last Close

0.98

17/05 20:00

Market Cap

224.94M

Beta: 0.73

Volume Today

403.34K

Avg: 2.73M

PE Ratio

−8.04

PFCF: −5.71

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-89.03M
-
-90.91M
2.11%
-51.46M
43.39%
-69.22M
34.49%
-77.99M
12.68%
-70.48M
9.63%
-66.89M
5.09%
-29.74M
55.54%
-17.91M
39.77%
-58.57M
226.97%
-25.09M
57.16%
depreciation and amortization
2.59M
-
2.36M
8.99%
1.44M
39.00%
941K
34.61%
465K
50.58%
594K
27.74%
683K
14.98%
706K
3.37%
1.16M
64.59%
998K
14.11%
1.24M
24.05%
deferred income tax
-98K
-
27K
-
-1.08M
4,107.41%
287K
-
-10.58M
-
stock based compensation
7.17M
-
9.79M
36.58%
7.40M
24.36%
7.33M
0.95%
5.99M
18.36%
7.70M
28.68%
9.12M
18.32%
7.30M
19.95%
9.49M
30.00%
12.38M
30.56%
8.81M
28.90%
change in working capital
-6.79M
-
-195K
97.13%
19.27M
9,980%
-15.79M
181.97%
-5.43M
65.62%
4.12M
175.91%
16.66M
304.15%
-30.32M
282.02%
9.72M
132.05%
-29.05M
398.92%
9.52M
132.76%
accounts receivables
-5.75M
-
5.55M
-
203K
96.34%
-4.08M
-
-6.03M
48.00%
-5.86M
2.85%
501K
108.55%
-24.85M
5,059.68%
9.77M
139.32%
inventory
1.37M
-
801K
-
2.09M
161.17%
-839K
-
-366K
56.38%
-126K
65.57%
-4.88M
3,769.05%
-2.38M
51.24%
1.17M
149.31%
accounts payables
2.21M
-
-2.29M
203.81%
1.15M
150.22%
2.80M
143.48%
-2.95M
205.25%
3.75M
227.42%
-2.24M
159.63%
-331K
85.22%
41K
112.39%
3.79M
9,139.02%
-366K
109.66%
other working capital
-4.61M
-
2.10M
145.41%
11.77M
461.72%
-20.89M
277.49%
-2.48M
88.11%
5.28M
312.77%
25.30M
378.86%
-24.00M
194.88%
14.05M
158.54%
-5.61M
139.94%
-1.06M
81.13%
other non cash items
9.30M
-
-57K
100.61%
818K
1,535.09%
495K
39.49%
-766K
254.75%
-1.07M
40.08%
-122K
88.63%
3.14M
2,672.95%
481K
84.68%
10.36M
2,054.47%
net cash provided by operating activities
-86.06M
-
-69.75M
18.95%
-23.41M
66.43%
-75.89M
224.13%
-77.56M
2.20%
-58.83M
24.15%
-41.51M
29.44%
-52.19M
25.72%
5.88M
111.26%
-73.76M
1,354.81%
-5.74M
92.21%
investments in property plant and equipment
-1.22M
-
-413K
66.18%
-546K
32.20%
-804K
47.25%
-164K
79.60%
-1.11M
574.39%
-1.46M
31.56%
-1.26M
13.26%
-627K
50.32%
-450K
28.23%
-15M
3,233.33%
acquisitions net
1.22M
-
1.11M
-
1.46M
31.56%
1.26M
13.26%
627K
50.32%
893K
42.42%
259K
71.00%
purchases of investments
-308.85M
-
-218.59M
29.22%
-151.76M
30.57%
-103.05M
32.10%
-116.86M
13.40%
-78.00M
33.26%
-145.33M
86.33%
-81.71M
43.78%
-141.46M
73.13%
-28.89M
79.57%
-31.21M
8.00%
sales maturities of investments
382.45M
-
281.70M
26.34%
196.86M
30.12%
128.65M
34.65%
96.82M
24.74%
104.07M
7.48%
123.13M
18.32%
130.43M
5.94%
62.05M
52.43%
101.23M
63.14%
41.65M
58.86%
other investing activites
-1.22M
-
234K
119.16%
60K
74.36%
88K
46.67%
732K
731.82%
-1.11M
251.09%
-1.46M
31.56%
-1.26M
13.26%
-627K
50.32%
net cash used for investing activites
72.38M
-
62.93M
13.05%
44.61M
29.11%
24.88M
44.23%
-19.47M
178.26%
24.96M
228.20%
-23.66M
194.76%
47.47M
300.65%
-80.04M
268.62%
72.78M
190.93%
-4.30M
105.90%
debt repayment
-9.79M
-
-9.97M
1.90%
-57.90M
480.45%
-4.43M
92.36%
-17.32M
291.28%
common stock issued
1.05M
-
1.17M
11.32%
5.29M
352.31%
23.59M
345.69%
114.18M
384.10%
67.16M
41.18%
1.58M
97.65%
2.60M
64.72%
4.78M
83.94%
2.12M
55.52%
1.05M
50.61%
common stock repurchased
dividends paid
other financing activites
1.76M
-
1.60M
9.26%
3.51M
119.52%
4.73M
34.89%
19.58M
313.74%
19.95M
1.90%
115.80M
480.45%
8.85M
92.36%
34.64M
291.28%
net cash used provided by financing activities
1.05M
-
1.17M
11.32%
7.05M
502.82%
25.18M
257.07%
117.69M
367.31%
71.89M
38.91%
11.37M
84.19%
12.57M
10.61%
62.67M
398.57%
6.55M
89.55%
18.37M
180.41%
effect of forex changes on cash
net change in cash
-12.63M
-
-5.65M
55.26%
28.25M
599.96%
-25.82M
191.40%
20.66M
180.00%
38.03M
84.10%
-53.80M
241.46%
7.85M
114.59%
-11.48M
246.24%
5.57M
148.50%
8.33M
49.52%
cash at beginning of period
33.48M
-
20.85M
37.72%
15.20M
27.10%
43.46M
185.84%
17.63M
59.43%
38.29M
117.16%
76.32M
99.33%
22.52M
70.49%
30.37M
34.87%
18.89M
37.81%
24.46M
29.48%
cash at end of period
20.85M
-
15.20M
27.10%
43.46M
185.84%
17.63M
59.43%
38.29M
117.16%
76.32M
99.33%
22.52M
70.49%
30.37M
34.87%
18.89M
37.81%
24.46M
29.48%
32.79M
34.04%
operating cash flow
-86.06M
-
-69.75M
18.95%
-23.41M
66.43%
-75.89M
224.13%
-77.56M
2.20%
-58.83M
24.15%
-41.51M
29.44%
-52.19M
25.72%
5.88M
111.26%
-73.76M
1,354.81%
-5.74M
92.21%
capital expenditure
-1.22M
-
-413K
66.18%
-546K
32.20%
-804K
47.25%
-164K
79.60%
-1.11M
574.39%
-1.46M
31.56%
-1.26M
13.26%
-627K
50.32%
-450K
28.23%
-15M
3,233.33%
free cash flow
-87.28M
-
-70.17M
19.61%
-23.96M
65.85%
-76.69M
220.10%
-77.72M
1.34%
-59.93M
22.89%
-42.97M
28.31%
-53.45M
24.40%
5.25M
109.82%
-74.21M
1,513.22%
-20.74M
72.05%

All numbers in USD (except ratios and percentages)